Cell Perturbation Screens For Target Identification By Rnai / Kubilay Demir And Michael Boutros -- Using Functional Genomics To Identify Drug Targets : A Dupuytren's Disease Example / Mirela Sedic, Sandra Kraljevic Pavelic, And Karlo Hock -- Functional Characterization Of Human Genes From Exon Expre
Cancer Drug Design and Discovery || Cancer drug resistance
โ Scribed by Karavasilis, V.
- Book ID
- 120043371
- Publisher
- Elsevier
- Year
- 2008
- Tongue
- English
- Weight
- 185 KB
- Edition
- 1
- Category
- Article
- ISBN
- 0123694485
No coin nor oath required. For personal study only.
โฆ Synopsis
The ultimate source of information on the design of new anticancer agents, emphasizing small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumors. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry and clinicians taking oncology options.
* Covers both currently available drugs as well as those under development
* Provides a clinical perspective on trials of new anticancer agents
* Presents drug discovery examples through the use of case histories
๐ SIMILAR VOLUMES
***Cancer Drug Design and Discovery, 2nd edition*** is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, includin
***Cancer Drug Design and Discovery, 2nd edition*** is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, includin
The ultimate source of information on the design of new anticancer agents, emphasizing small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that